NPI: 1710941356 · HUNTINGDON, TN 38344 · General Acute Care Hospital · NPI assigned 04/12/2006
Authorized official DUCKETT, GREGORY controls 20+ related entities in our dataset. Read more
| Authorized Official | DUCKETT, GREGORY (SR VP / CLO) |
| Parent Organization | BAPTIST MEMORIAL HEALTH CARE CORP. |
| NPI Enumeration Date | 04/12/2006 |
Other providers sharing the same authorized official: DUCKETT, GREGORY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 6,636 | $202K |
| 2019 | 10,869 | $287K |
| 2020 | 7,667 | $210K |
| 2021 | 10,302 | $301K |
| 2022 | 14,106 | $449K |
| 2023 | 20,103 | $617K |
| 2024 | 11,240 | $422K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4,267 | 3,332 | $657K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 5,019 | 4,280 | $641K |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 6,732 | 5,944 | $611K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 2,014 | 1,780 | $67K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 10,709 | 8,565 | $56K |
| G0378 | Hospital observation service, per hour | 1,115 | 461 | $55K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 977 | 883 | $50K |
| 80053 | Comprehensive metabolic panel | 11,161 | 8,920 | $45K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,245 | 1,042 | $43K |
| 71045 | Radiologic examination, chest; single view | 2,864 | 2,240 | $31K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2,376 | 2,115 | $26K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 12 | 12 | $25K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2,562 | 2,119 | $24K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3,577 | 1,586 | $22K |
| 84484 | 2,162 | 1,119 | $20K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 667 | 532 | $19K |
| 36415 | Collection of venous blood by venipuncture | 11,310 | 8,799 | $16K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 4,031 | 2,392 | $14K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 376 | 349 | $10K |
| 83735 | 1,875 | 1,482 | $8K | |
| 71046 | Radiologic examination, chest; 2 views | 331 | 298 | $7K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 54 | 48 | $7K |
| 96361 | Intravenous infusion, hydration; each additional hour | 147 | 65 | $4K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 29 | 25 | $4K |
| 83605 | 469 | 344 | $3K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 56 | 50 | $3K |
| 81003 | 3,019 | 2,517 | $3K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 182 | 129 | $2K |
| 70450 | Computed tomography, head or brain; without contrast material | 88 | 62 | $2K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 167 | 163 | $2K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 42 | 38 | $1K |
| 72100 | 82 | 65 | $940.98 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 39 | 38 | $800.00 |
| 76801 | 14 | 13 | $759.14 | |
| 0012A | 24 | 17 | $640.00 | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 12 | 12 | $590.57 |
| 87807 | 58 | 57 | $585.95 | |
| 85027 | 191 | 145 | $548.44 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 15 | 13 | $491.66 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 14 | 12 | $382.09 |
| 83690 | 45 | 39 | $308.98 | |
| 96376 | 26 | 14 | $226.85 | |
| 82150 | 32 | 27 | $145.11 | |
| 84703 | 31 | 24 | $143.16 | |
| 80048 | Basic metabolic panel (calcium, ionized) | 47 | 36 | $128.61 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 46 | 43 | $56.28 |
| 81025 | 16 | 13 | $21.92 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 46 | 41 | $18.72 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 14 | 12 | $12.40 |
| A9270 | Non-covered item or service | 258 | 155 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 103 | 91 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 17 | 17 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 35 | 29 | $0.00 |
| A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | 59 | 51 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 17 | 13 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 33 | 27 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 14 | 12 | $0.00 |